Statin prescribing according to gender, age and indication: what about the benefit-risk balance?-Reference-Cited by-同舟云学术

Statin prescribing according to gender, age and indication: what about the benefit-risk balance?

Published:2015-10-08 Issue:2 Volume:22 Page:235-246
ISSN:1356-1294
Container-title:Journal of Evaluation in Clinical Practice
language:en
Short-container-title:J Eval Clin Pract

Author:

Wallach-Kildemoes Helle¹,Stovring Henrik²,Holme Hansen Ebba³,Howse Kenneth⁴,Pétursson Hálfdán⁵

Affiliation:

1. Section for Social and Clinical Pharmacy; Department of Pharmacy; Faculty of Health and Medical Science; University of Copenhagen; Copenhagen Denmark

2. Biostatistics; Department of Public Health; University of Aarhus; Aarhus Denmark

3. Section for Social and Clinical Pharmacy; University of Copenhagen; Copenhagen Denmark

4. Oxford Institute of Population Ageing; University of Oxford; Oxford UK

5. General Practice Research Unit; Department of Public Health and General Practice; Norwegian University of Science and Technology; Trondheim Norway

Publisher

Wiley

Subject

Public Health, Environmental and Occupational Health,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jep.12462/fullpdf

Reference96 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Pedersen;Lancet,1994

2. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient;Ong;QJM: Monthly Journal of the Association of Physicians,2005

3. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts);Graham;European Heart Journal,2007

4. Christensen , B. Faergemann , O. Heebøll-Nielsen , N. Lous , J. Madsen , L. D. Stender , S. 2007 Forebyggelse af iskaemisk hjertekarsygdom i almen praksis. En klinisk vejledning (3) [Prevention of ischemic cardiovascular disease in general practice. A clinical guideline (3).]

5. Statins for all by the age of 50 years?;Ebrahim;Lancet,2012

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between Statin use and Incident Peripheral Artery Disease According to Race, Age, and Presence of Depression in the Multi-Ethnic Study of Atherosclerosis;Annals of Vascular Surgery;2024-05

2. Italian Association of Hospital Cardiologists Position Paper ‘Gender discrepancy: time to implement gender-based clinical management’;European Heart Journal Supplements;2024-04

3. Cholesterol-lowering medications and sarcopenia: Large cross- sectional Study ：NHANES 2011-2014;2024-03-06

4. Effect of statin treatment on metabolites, lipids and prostanoids in patients with Statin Associated Muscle Symptoms (SAMS);PLOS ONE;2023-12-15

5. Statin Eligibility according to 2013 ACC/AHA and USPSTF Guidelines among Jordanian Patients with Acute Myocardial Infarction: The Impact of Gender;Cardiovascular Therapeutics;2023-06-05